Table of Contents
| << Previous Issue | Apr 2007 (Vol: 2007, Issue: 82) | Next Issue >> |
- Section: Business Commentaries
-
How Virtual Biotech has Changed the World
- Section: Cartoons
-
Security
- Section: Deal Trackers
-
Vyvanse (lisdexamfetamine dimesylate)
- Section: Features
-
BioCryst: The Fall and Rise of Peramivir
-
Cytyc - A Positive Outlook
-
Valuation Methodologies in Biotech
-
Therapy Focus: Attention Deficit Hyperactivity Disorder
- Section: General
-
Wyeth Alters R&D to Address the Emerging Challenges Facing Biotech
-
MediGene AG
- Section: Licensing
-
Salix Expands Product Portfolio through Merck & Co. Licensing Deal
- Section: Mergers & Acquisitions
-
Schering-Plough in US$14.4 B Acquisition of Organon BioSciences
-
Smith & Nephew’s Acquisition of Plus Orthopedics Makes it Key Player in Reconstructive Surgery Market
- Section: Research & Development
-
Bristol-Myers Squibb and Adnexus Therapeutics in Collaboration for Cancer Biologics
-
Avalon Enters into Collaborative R&D Deal Worth a Potential US$200 M
RSS